We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+12.2%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$281B
AUM Growth
+$27.1B
Cap. Flow
+$2.74B
Cap. Flow %
0.97%
Top 10 Hldgs %
27.23%
Holding
2,593
New
53
Increased
939
Reduced
858
Closed
73

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$274M
2
UNH icon
UnitedHealth
UNH
+$207M
3
SPLK
Splunk Inc
SPLK
+$204M
4
HD icon
Home Depot
HD
+$203M
5
QCOM icon
Qualcomm
QCOM
+$200M

Sector Composition

Rank Sector Weight
1 Technology 31.71%
2 Healthcare 12.08%
3 Financials 11.18%
4 Consumer Discretionary 10.43%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRDS icon
2426
NerdWallet
NRDS
$632M
$147K ﹤0.01%
10,000
MCS icon
2427
Marcus Corp
MCS
$762M
$146K ﹤0.01%
10,225
PLL
2428
DELISTED
Piedmont Lithium
PLL
$143K ﹤0.01%
+10,711
New +$172K
TTEC icon
2429
TTEC Holdings
TTEC
$120M
$138K ﹤0.01%
13,269
PHAT icon
2430
Phathom Pharmaceuticals
PHAT
$932M
$137K ﹤0.01%
12,893
SPRY icon
2431
ARS Pharmaceuticals
SPRY
$552M
$132K ﹤0.01%
12,940
OLPX
2432
DELISTED
Olaplex Holdings
OLPX
$128K ﹤0.01%
66,515
REPL icon
2433
Replimune Group
REPL
$429M
$117K ﹤0.01%
14,380
TERN
2434
DELISTED
Terns Pharmaceuticals
TERN
$117K ﹤0.01%
17,870
CLOV icon
2435
Clover Health Investments
CLOV
$2.24B
$113K ﹤0.01%
141,869
GRNT icon
2436
Granite Ridge Resources
GRNT
$621M
$99.5K ﹤0.01%
15,300
TNGX icon
2437
Tango Therapeutics
TNGX
$4.16B
$96.9K ﹤0.01%
12,200
SHCR
2438
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$93.9K ﹤0.01%
122,400
ME
2439
DELISTED
23andMe Holding Co
ME
$89.5K ﹤0.01%
8,407
SVRA icon
2440
Savara
SVRA
$1.07B
$86.2K ﹤0.01%
+17,300
New +$83.6K
SEAT icon
2441
Vivid Seats
SEAT
$82M
$85K ﹤0.01%
709
HLLY icon
2442
Holley
HLLY
$331M
$84.8K ﹤0.01%
19,010
LYEL icon
2443
Lyell Immunopharma
LYEL
$317M
$73.6K ﹤0.01%
1,650
SES icon
2444
SES AI
SES
$188M
$72.6K ﹤0.01%
43,234
BNDX icon
2445
Vanguard Total International Bond ETF
BNDX
$82B
$65.2K ﹤0.01%
+1,326
New +$64.8K
AMLX icon
2446
Amylyx Pharmaceuticals
AMLX
$2.14B
$55.9K ﹤0.01%
19,700
CRCT icon
2447
Cricut
CRCT
$999M
$55.4K ﹤0.01%
11,639
BIG
2448
DELISTED
Big Lots, Inc.
BIG
$53.3K ﹤0.01%
+12,314
New +$65.1K
DAC icon
2449
Danaos Corp
DAC
$2.53B
$48.2K ﹤0.01%
+667
New +$49.2K
SAVAW
2450
DELISTED
Cassava Sciences, Inc. Warrant
SAVAW
$45K ﹤0.01%
+11,172
New +$66.7K

Similar funds

UBS AM's Q1 2024 Portfolio in Review

As of Q1 2024, UBS AM held 2,593 positions worth $281B, up 11% from $254B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 4.9%. UBS AM opened 53 new positions and exited 73, leaving the 2,593-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • UBS AM's largest Q1 2024 buy was iShares Core MSCI EAFE ETF: 57,224,039 shares worth $4.25B.
  • UBS AM added most to Costco in Q1 2024, an estimated $252M increase.
  • UBS AM's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $274M.
  • UBS AM fully exited Splunk Inc in Q1 2024, selling an estimated $204M.
  • UBS AM's ten largest holdings make up 27% of its $281B portfolio in Q1 2024.
  • UBS AM opened 53 new positions and closed 73 in Q1 2024.
  • UBS AM's portfolio value rose 11% quarter-over-quarter to $281B.

Based on UBS AM's 13F filing for Q1 2024, filed 15 May 2024.